NAD+ Precursors Show Promise for Cognitive Disease Treatment
Recent advancements in neuroscience have pointed towards the therapeutic potential of nicotinamide adenine dinucleotide (NAD+) precursors for treating cognitive diseases, particularly as the aging population...
















